The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Ljungman, Per, Mikulska, Malgorzata, de la Camara, Rafael, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Duarte, Rafael, Dolstra, Harry, Lankester, Arjan C., Mohty, Mohamad, Montoto, Silvia, Murray, John, Peffault de Latour, Régis, Snowden, John A., Yakoub-Agha, Ibrahim, Verhoeven, Bregje, Kröger, Nicolaus, Styczynski, Jan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Perspective
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220575/
https://ncbi.nlm.nih.gov/pubmed/32404975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0919-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados